ShawnP123, even if Fluticare doesn't get approved in Q1-2017, it could still get approval all the way up to Q4 -2017, but the longer it takes, the less of a positive impact it will have.
I don't think Fluticare approval will result in any INNV trading halt, what do you think?
Yes, there are already so many approved fluticare OTC generics, that INNVs sales will probably mostly be limited to online and even if they could get it on the store shelves, they can't compete with the low prices of Costco, etc. and even if they could compete with those low prices, the profit margin would be so slim, like .01 cents per sale, that it won't have much of a positive effect on sales or the share price.
What do you think of all that? Isn't that also your basic view on it?
